21474db6cdf3a2fc…
StudyID:
NCT00074529681 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | An investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease. |
| completionDate | 2006-01 |
| conditions | ["Alzheimer's Disease"] |
| enrollmentCount | 512 |
| enrollmentType | ACTUAL |
| nctId | NCT00074529 |
| phase | PHASE2 |
| sponsorId | merck-sharp-dohme-llc |
| startDate | 2003-10 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease |
| url | https://clinicaltrials.gov/study/NCT00074529 |
Canonical JSON
{
"id": "NCT00074529",
"type": "Study",
"data": {
"briefSummary": "An investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease.",
"completionDate": "2006-01",
"conditions": [
"Alzheimer's Disease"
],
"enrollmentCount": 512,
"enrollmentType": "ACTUAL",
"nctId": "NCT00074529",
"phase": "PHASE2",
"sponsorId": "merck-sharp-dohme-llc",
"startDate": "2003-10",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease",
"url": "https://clinicaltrials.gov/study/NCT00074529"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:21474db6cdf3a2fcd129ee4a3ea74e7c593ca63bb911bceebb9620d6102a12ca